-
$CDTX (1of3) I'm buying betw. $2.65-$3. Rezafungin is a solid product in Phase 3, reading out later 2020. In Sep CDTX signed a $568mm (potential) deal for EX-U.S. & Japan rights (see pic). Recent cap. raise through rights offering & above deal is done. Technicals good, see chart pic.twitter.com/vPMFhooHUh
Prikaži ovu nit -
$CDTX dropping below $3.00/share from $4.40 is a red-line
for me. Expected more institutional support, esp trading as high as $4.00 from CANTOR analyst Ms Chen’s comments referencing Wuhan-nCoV/CLOUDBREAK. More appropriate to speak of REZAFUNGIN value. Doesn’t smell right. -
I wonder why? Rezafungin seems to be a decent drug in need? Kind of sends the wrong message to investors.
$CDTX -
Yes, market-manipulation at it’s best. Still, I think
$CDTX REZAFUNGIN drug is important and valuable and ‘back-stabbers’ I mean ‘back-stoppers’ BVF and Stonepine Capital know it. Kind of sucks individual investors have to be subjugated to this trading pattern. Schizophrenic! -
$CDTX trading not v shareholder friendly trading pattern last week. Asking for Rights Offer from existing shareholders and then trading down for a week. Anyone able analyze the trades last five (5) days after CANTOR’S comments on CLOUDBREAK and Wuhan nCoV outbreak?Prikaži ovu nit -
-
That
$CDTX rights offering at $2.51/share is looking a lot less attractive as we approach the expiration date. -
What about Cidara Therapeutics’ REZAFUNGIN, currently in Phase-3 (ReSTORE)trial for candidemia. Not sure if trial includes ‘a pregnant patient.’
$CDTX -
$CDTX Looking worse than ever. -7.90 % change recently https://blueequity.io/symbol/CDTX -
NICE, shows conviction.
$CDTX -
$CDTX: New Insider Filing on Chief Financial Officer JAMES E. LEVINE: http://insideri.com/1610618_000120919120005704_0001209191-20-005704 … -
$CDTX Cidara Therapeutics, Inc. SEC Filing: Form 4 http://www.sec.gov/Archives/edgar/data/1463151/000120919120005704/xslF345X03/doc4.xml … -
SELL ALERT: I have just sold
$CDTX. The stock price dropped below 88% of the original (averaged) purchase price. -
$CDTX a bit volatility -5.20 % change recently https://blueequity.io/symbol/CDTX -
Squeeze play pattern detected by our stock screener for
$BANC,$CDTX and$ZYME. https://www.chartmill.com/stock/stock-screener?sid=12&f=sqds,v1_50b300,sl_ti_105_X,exch_us&v=3&timeframe=DAILY&type=CANDLES&months=0.05&width=400&cl=F&o1=0&o2=57&op1=14&op2=20,1.5,10&utm_source=twitterUS&utm_medium=screener&utm_content=Stock_Screener:_Momentum_Squeeze_Play_Setups&utm_campaign=social_tracking … -
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.